» Articles » PMID: 23710041

Presenilin Controls Kinesin-1 and Dynein Function During APP-vesicle Transport in Vivo

Overview
Journal Hum Mol Genet
Date 2013 May 28
PMID 23710041
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Neurons and other cells require intracellular transport of essential components for viability and function. Previous work has shown that while net amyloid precursor protein (APP) transport is generally anterograde, individual vesicles containing APP move bi-directionally. This discrepancy highlights our poor understanding of the in vivo regulation of APP-vesicle transport. Here, we show that reduction of presenilin (PS) or suppression of gamma-secretase activity substantially increases anterograde and retrograde velocities for APP vesicles. Strikingly, PS deficiency has no effect on an unrelated cargo vesicle class containing synaptotagmin, which is powered by a different kinesin motor. Increased velocities caused by PS or gamma-secretase reduction require functional kinesin-1 and dynein motors. Together, our findings suggest that a normal function of PS is to repress kinesin-1 and dynein motor activity during axonal transport of APP vesicles. Furthermore, our data suggest that axonal transport defects induced by loss of PS-mediated regulatory effects on APP-vesicle motility could be a major cause of neuronal and synaptic defects observed in Alzheimer's Disease (AD) pathogenesis. Thus, perturbations of APP/PS transport could contribute to early neuropathology observed in AD, and highlight a potential novel therapeutic pathway for early intervention, prior to neuronal loss and clinical manifestation of disease.

Citing Articles

Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update.

Huang L, Kuan Y, Lin H, Hu C J Biomed Sci. 2023; 30(1):83.

PMID: 37784171 PMC: 10544555. DOI: 10.1186/s12929-023-00976-6.


Ketamine Reduces the Surface Density of the Astroglial Kir4.1 Channel and Inhibits Voltage-Activated Currents in a Manner Similar to the Action of Ba on K Currents.

Bozic M, Pirnat S, Fink K, Potokar M, Kreft M, Zorec R Cells. 2023; 12(10).

PMID: 37408194 PMC: 10216244. DOI: 10.3390/cells12101360.


Glycogen synthase kinase 3β (GSK3β) and presenilin (PS) are key regulators of kinesin-1-mediated cargo motility within axons.

Banerjee R, Gunawardena S Front Cell Dev Biol. 2023; 11:1202307.

PMID: 37363727 PMC: 10288942. DOI: 10.3389/fcell.2023.1202307.


Short-Term and Long-Term Sensitization Differentially Alters the Composition of an Anterograde Transport Complex in .

Sadhu A, Badal K, Zhao Y, Ali A, Swarnkar S, Tsaprailis G eNeuro. 2022; 10(1).

PMID: 36549915 PMC: 9829102. DOI: 10.1523/ENEURO.0266-22.2022.


HTT (huntingtin) and RAB7 co-migrate retrogradely on a signaling LAMP1-containing late endosome during axonal injury.

Krzystek T, White J, Rathnayake R, Thurston L, Hoffmar-Glennon H, Li Y Autophagy. 2022; 19(4):1199-1220.

PMID: 36048753 PMC: 10012955. DOI: 10.1080/15548627.2022.2119351.


References
1.
Kang D, Soriano S, Xia X, Eberhart C, De Strooper B, Zheng H . Presenilin couples the paired phosphorylation of beta-catenin independent of axin: implications for beta-catenin activation in tumorigenesis. Cell. 2002; 110(6):751-62. DOI: 10.1016/s0092-8674(02)00970-4. View

2.
Reis G, Yang G, Szpankowski L, Weaver C, Shah S, Robinson J . Molecular motor function in axonal transport in vivo probed by genetic and computational analysis in Drosophila. Mol Biol Cell. 2012; 23(9):1700-14. PMC: 3338437. DOI: 10.1091/mbc.E11-11-0938. View

3.
Ye Y, Lukinova N, Fortini M . Neurogenic phenotypes and altered Notch processing in Drosophila Presenilin mutants. Nature. 1999; 398(6727):525-9. DOI: 10.1038/19096. View

4.
Marfany G, Del-Favero J, Valero R, de Jonghe C, Woodrow S, Hendriks L . Identification of a Drosophila presenilin homologue: evidence of alternatively spliced forms. J Neurogenet. 1998; 12(1):41-54. DOI: 10.3109/01677069809108554. View

5.
Tran H, LaFerla F, Holtzman D, Brody D . Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-β accumulation and independently accelerates the development of tau abnormalities. J Neurosci. 2011; 31(26):9513-25. PMC: 3146343. DOI: 10.1523/JNEUROSCI.0858-11.2011. View